SOLID BIOSCIENCES INC
SLDBNASDAQ🏆 #2150 by market capEarnings Nov 2US Equity
$8.85▲ $0.30 (+3.39%)
Market closed · at close1h—
24h▲ 3.4%
7d▲ 1.1%
14d▲ 10.3%
30d▼ 9.2%
1y▲ 47.0%
🏦Market Cap
$871M
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
60.4x
Expensive
Otter Score
47
Weak
📊
Analyst Ratings
Price
$8.85
Total
21
Raised
1
Lowered
1
Avg PT
$17.00
H / L
$18 / $16
| Institution | Action | Rating | Date |
|---|---|---|---|
HC Wainwright & Co. | Reiterated | Buy | 2026-06-03 |
Wedbush | Reiterated | Outperform | 2026-05-18 |
Piper Sandler | Reiterated | Overweight | 2026-05-13 |
JP Morgan | Reiterated | Overweight | 2026-03-25 |
Needham | Reiterated | Buy | 2026-03-20 |
Chardan Capital | Reiterated | Buy | 2026-03-20 |
Citigroup | Reiterated | Buy | 2025-11-05 |
Barclays | Reiterated | Overweight | 2025-11-04 |
JMP Securities | Reiterated | Market Outperform | 2025-06-06 |
Citizens Capital Markets | Reiterated | Market Outperform | 2025-03-07 |
HC Wainwright& Co. | Reiterated | Buy | 2024-12-12 |
Leerink Partners | Upgraded | Market Perform → Outperform | 2024-06-24 |
SVB Leerink | Reiterated | Market Perform | 2022-11-10 |
Jefferies | Reiterated | Buy | 2021-05-27 |
Credit Suisse | Reiterated | Neutral | 2021-03-16 |
Nomura | Reiterated | Buy | 2020-05-08 |
Evercore ISI Group | Reiterated | Outperform | 2019-10-11 |
Leerink Swann | Downgraded | Outperform → Market Perform | 2019-02-08 |
BTIG Research | Reiterated | Neutral | 2018-12-10 |
Goldman Sachs | Reiterated | Neutral | 2018-02-20 |
Instinet | Reiterated | Buy | 2018-02-20 |
One row per institution, most recent rating